PHARMA XP CONSULTING LTD

Company Registration Number:
08862562 (England and Wales)

Unaudited micro entity accounts for the year ended 31 January 2023

Period of accounts

Start date: 01 February 2022

End date: 31 January 2023

PHARMA XP CONSULTING LTD

Contents of the Financial Statements

for the Period Ended 31 January 2023

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

PHARMA XP CONSULTING LTD

Company Information

for the Period Ended 31 January 2023




Registered office: Billingscroft
2 Farquhar Street
Hertford
SG14 3BP
Company Registration Number: 08862562 (England and Wales)

PHARMA XP CONSULTING LTD

Profit and Loss Account

for the Period Ended 31 January 2023


2023
£

2022
£
Turnover 443 210
Other charges ( 477 ) ( 218 )
Profit or (Loss) for Period ( 34 ) ( 8 )

PHARMA XP CONSULTING LTD

Balance sheet

As at 31 January 2023


2023
£

2022
£
Called up share capital not paid: 10,000 10,000
Current assets: 1,691 1,725
Net current assets (liabilities): 1,691 1,725
Total assets less current liabilities: 11,691 11,725
Total net assets (liabilities): 11,691 11,725
Capital and reserves: 11,691 11,725

PHARMA XP CONSULTING LTD

Balance sheet continued

For the year ending 31 January 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 22 October 2023
And Signed On Behalf Of The Board By:

Name: Dr Christian Seiler
Status: Director

The notes form part of these financial statements

PHARMA XP CONSULTING LTD

Footnotes to the Financial Statements

for the Period Ended 31 January 2023

  • 1. Employee Information

    Average number of employees: 1

PHARMA XP CONSULTING LTD

Footnotes to the Financial Statements

for the Period Ended 31 January 2023

  • 2. Off balance sheet disclosure

    No